Chang J Y, Han F S, Liu S Y, Wang Z Q, Lee K H, Cheng Y C
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.
Cancer Res. 1991 Apr 1;51(7):1755-9.
Six 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin were examined for inhibitory activity against human DNA topoisomerase II and tubulin polymerization, their ability to generate protein-linked DNA breaks in cells, and their cytotoxicity toward the KB cell line and its VP-16- and vincristine-resistant variants. Five of these derivatives were 5- to 10-fold more potent than VP-16 as inhibitors of DNA topoisomerase II in vitro, and all of these derivatives could generate the same amount of or more protein-linked DNA breaks in cells than VP-16 at 1-20 microMs. Tubulin polymerization was inhibited by these compounds to different degrees in the order: podophyllotoxin greater than W73 greater than W87 greater than NPF greater than NPC greater than W68 greater than W38 greater than VP-16. These analogues were cytotoxic not only to KB cells but also to their VP-16-resistant and vincristine-resistant variants which showed decreased cellular uptake of VP-16 and a decrease in DNA topoisomerase II content or overexpression of MDR1 phenotype. These characteristics may cause these derivatives to have different spectrums of antitumor activity.
研究了4'-O-去甲基表鬼臼毒素的六种4-β-芳氨基衍生物对人DNA拓扑异构酶II和微管蛋白聚合的抑制活性、它们在细胞中产生蛋白质连接的DNA断裂的能力以及它们对KB细胞系及其VP-16和长春新碱抗性变体的细胞毒性。其中五种衍生物作为DNA拓扑异构酶II的体外抑制剂比VP-16强5至10倍,并且在1至20微摩尔浓度下,所有这些衍生物在细胞中产生的蛋白质连接的DNA断裂量与VP-16相同或更多。这些化合物对微管蛋白聚合的抑制程度不同,顺序为:鬼臼毒素大于W73大于W87大于NPF大于NPC大于W68大于W38大于VP-16。这些类似物不仅对KB细胞具有细胞毒性,而且对其VP-16抗性和长春新碱抗性变体也具有细胞毒性,这些变体显示出VP-16的细胞摄取减少以及DNA拓扑异构酶II含量降低或MDR1表型过表达。这些特性可能导致这些衍生物具有不同的抗肿瘤活性谱。